Location History:
- Pusan, KR (2002)
- Taejon-si, KR (2001 - 2008)
- Taejeon-si, KR (2008)
- Daejeon, KR (1993 - 2012)
Company Filing History:
7 out of 624 
3 out of 12 
1 out of 3,792 
Years Active: 1993-2025
Title: Byung Ho Lee: Innovator in PDE9A Inhibitory Compounds
Introduction
Byung Ho Lee is a prominent inventor based in Taejon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with PDE9A inhibitory activity. With a total of 12 patents to his name, Lee's work has the potential to impact the treatment of various diseases.
Latest Patents
Among his latest patents, Lee has developed compounds that exhibit PDE9A inhibitory activity. These compounds are characterized by a specific chemical structure and can be used in pharmaceutical applications. The inventions include compositions containing these compounds or their pharmaceutically acceptable salts. Furthermore, Lee's patents outline methods for treating or preventing PDE9A-related diseases by administering effective amounts of these compounds or compositions to patients in need.
Career Highlights
Lee has worked with notable organizations such as the Korea Research Institute of Chemical Technology and Dongbu Hannong Chemical Co., Ltd. His experience in these institutions has allowed him to refine his expertise in chemical technology and pharmaceutical development.
Collaborations
Some of Lee's notable coworkers include Kyu Yang Yi and Jee Hee Suh. Their collaborative efforts have contributed to the advancement of research in the field of PDE9A inhibitors.
Conclusion
Byung Ho Lee's innovative work in developing PDE9A inhibitory compounds showcases his dedication to advancing pharmaceutical science. His contributions are poised to make a significant impact on the treatment of related diseases.